Effects of Antipsychotics on the Inflammatory Response System of Patients with Schizophrenia in Peripheral Blood Mononuclear Cell Cultures

키워드

참고문헌 (57)

1. Hänninen K, "Interleukin-1 beta gene polymorphism and its interactions with neuregulin-1 gene polymorphism are associated with schizophrenia", Eur Arch Psychiatry Clin Neurosci, 258, pp.10~15 (2008)
2. Anderson G, "Schizophrenia: linking prenatal infection to cytokines, the tryptophan catabolite (TRYCAT) pathway, NMDA receptor hypofunction, neurodevelopment and neuroprogression", Prog Neuropsychopharmacol Biol Psychiatry, 42, pp.5~19 (2013)
3. Drzyzga L, "Cytokines in schizophrenia and the effects of antipsychotic drugs", Brain Behav Immun, 20, pp.532~545 (2006)
4. Karanikas EP, "Psycho-immunological mechanisms in schizophrenia", Psychiatrike, 22, pp.43~52 (2011)
5. Gardiner EJ, "Gene expression analysis reveals schizophreniaassociated dysregulation of immune pathways in peripheral blood mononuclear cells", J Psychiatr Res, 47, pp.425~437 (2013)
6. Rothermundt M, "Immunological dysfunction in schizophrenia: a systematic approach", Neuropsychobiology, 37, pp.186~193 (1998)
7. Zorrilla EP, "Leukocytes and organ-nonspecific autoantibodies in schizophrenics and their siblings: markers of vulnerability or disease?", Biol Psychiatry, 40, pp.825~833 (1996)
8. Theodoropoulou S, "Cytokine serum levels, autologous mixed lymphocyte reaction and surface marker analysis in never medicated and chronically medicated schizophrenic patients", Schizophr Res, 47, pp.13~25 (2001)
9. Wilke I, "Investigations of cytokine production in whole blood cultures of paranoid and residual schizophrenic patients", Eur Arch Psychiatry Clin Neurosci, 246, pp.279~284 (1996)
10. Maino K, "T- and B-lymphocytes in patients with schizophrenia in acute psychotic episode and the course of the treatment", Psychiatry Res, 152, pp.173~180 (2007)
11. Craddock RM, "Altered T-cell function in schizophrenia: a cellular model to investigate molecular disease mechanisms", PLoS One, 2, pp.e692~ (2007)
12. Steiner J, "Acute schizophrenia is accompanied by reduced T cell and increased B cell immunity", Eur Arch Psychiatry Clin Neurosci, 260, pp.509~518 (2010)
13. Mach DM, "Schizophrenia and B-lymphocyte alteration-a hypothesis", Psychiatr Neurol Med Psychol (Leipz), 35, pp.390~397 (1983)
14. Miller BJ, "Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects", Biol Psychiatry, 70, pp.663~671 (2011)
15. Barak V, "Changes in interleukin-1 beta and soluble interleukin-2 receptor levels in CSF and serum of schizophrenic patients", J Basic Clin Physiol Pharmacol, 6, pp.61~69 (1995)
16. Di Nicola M, "Serum and gene expression profile of cytokines in first-episode psychosis", Brain Behav Immun, 31, pp.90~95 (2013)
17. Müller M, "Immune system and schizophrenia", Curr Immunol Rev, 6, pp.213~220 (2010)
18. Chiang SSW, "In vivo type II T-helper cells shift in schizophrenia compared to sex- and age-matched healthy controls", Eur J Psychiat, 25, pp.192~204 (2011)
19. García-Bueno B, "Martínez-Cengotitabengoa M, Pina-Camacho L, et al. Pro-", Anti-inflammatory dysregulation in patients with first episode of psychosis: toward an integrative inflammatoryhypothesis of schizophrenia, 2013, ~
20. Maes M, "Interleukin-2 and interleukin-6 in schizophrenia and mania: effects of neuroleptics and mood stabilizers", J Psychiatr Res, 29, pp.141~152 (1995)
21. Lin A, "The inflammatory response system in treatmentresistant schizophrenia: increased serum interleukin-6", Schizophr Res, 32, pp.9~15 (1998)
22. Naudin J, "A differential role for interleukin-6 and tumor necrosis factor-alpha in schizophrenia?", Schizophr Res, 26, pp.227~233 (1997)
23. O'Brien SM, "Increased tumor necrosis factor-alpha concentrations with interleukin-4 concentrations in exacerbations of schizophrenia", Psychiatry Res, 160, pp.256~262 (2008)
24. Arolt V, "Decreased in vitro production of interferon-gamma and interleukin-2 in whole blood of patients with schizophrenia during treatment", Mol Psychiatry, 5, pp.150~158 (2000)
25. Bessler H, "Cytokine production in drug-free and neuroleptic- treated schizophrenic patients", Biol Psychiatry, 38, pp.297~302 (1995)
26. Monteleone P, "Plasma levels of interleukin-6 and tumor necrosis factor alpha in chronic schizophrenia: effects of clozapine treatment", Psychiatry Res, 71, pp.11~17 (1997)
27. Kamińska T, "Investigation of serum cytokine levels and cytokine production in whole blood cultures of paranoid schizophrenic patients", Arch Immunol Ther Exp (Warsz), 49, pp.439~445 (2001)
28. Avgustin B, "Increased Th1 and Th2 immune reactivity with relative Th2 dominance in patients with acute exacerbation of schizophrenia", Croat Med J, 46, pp.268~274 (2005)
29. Inglot AD, "Interferon responses in schizophrenia and major depressive disorders", Biol Psychiatry, 35, pp.464~473 (1994)
30. Kim YK, "Th1, Th2 and Th3 cytokine alteration in schizophrenia", Prog Neuropsychopharmacol Biol Psychiatry, 28, pp.1129~1134 (2004)
31. Rothermundt M, "Production of cytokines in acute schizophrenic psychosis", Biol Psychiatry, 40, pp.1294~1297 (1996)
32. Cazzullo CL, "Cytokines production in chronic schizophrenia patients with or without paranoid behaviour", Prog Neuropsychopharmacol Biol Psychiatry, 22, pp.947~957 (1998)
33. Mittleman BB, "Cerebrospinal fluid cytokines in pediatric neuropsychiatric disease", J Immunol, 159, pp.2994~2999 (1997)
34. Schwarz MJ, "T-helper-1 and T-helper-2 responses in psychiatric disorders", Brain Behav Immun, 15, pp.340~370 (2001)
35. Schwarz MJ, "The Th2-hypothesis of schizophrenia: a strategy to identify a subgroup of schizophrenia caused by immune mechanisms", Med Hypotheses, 56, pp.483~486 (2001)
36. Kim YK, "Cytokine changes and tryptophan metabolites in medication-naïve and medication-free schizophrenic patients", Neuropsychobiology, 59, pp.123~129 (2009)
37. Zhang XY, "Changes in serum interleukin-2, -6, and -8 levels before and during treatment with risperidone and haloperidol: relationship to outcome in schizophrenia", J Clin Psychiatry, 65, pp.940~947 (2004)
38. Leykin I, "Short and long-term immunosuppressive effects of clozapine and haloperidol", Immunopharmacology, 37, pp.75~86 (1997)
39. Szuster-Ciesielska A, "Neuroleptics modulate cytokine and reactive oxygen species production in blood leukocytes of healthy volunteers", Arch Immunol Ther Exp (Warsz), 52, pp.59~67 (2004)
40. Rudolf S, "\The influence of typical and atypical neuroleptic drugs in the production of interleukin-2 and interferon-gamma in vitro", Neuropsychobiology, 46, pp.180~185 (2002)
41. Sugino H, "Atypical antipsychotics suppress production of proinflammatory cytokines and up-regulate interleukin-10 in lipopolysaccharide- treated mice", Prog Neuropsychopharmacol Biol Psychiatry, 33, pp.303~307 (2009)
42. Maes M, "Immune-inflammatory markers in schizophrenia: comparison to normal controls and effects of clozapine", Acta Psychiatr Scand, 89, pp.346~351 (1994)
43. Haack M, "Plasma levels of cytokines and soluble cytokine receptors in psychiatric patients upon hospital admission: effects of confounding factors and diagnosis", J Psychiatr Res, 33, pp.407~418 (1999)
44. Pollmächer T, "Clozapine-induced increase in plasma levels of soluble interleukin-2 receptors", Arch Gen Psychiatry, 52, pp.877~878 (1995)
45. Kato T, "Risperidone significantly inhibits interferon-gamma-induced microglial activation in vitro", Schizophr Res, 92, pp.108~115 (2007)
46. Lü LX, "Effect of clozapine and risperidone on serum cytokine levels in patients with first-episode paranoid schizophrenia", Di Yi Jun Yi Da Xue Xue Bao, 24, pp.1251~1254 (2004)
47. Cazzullo CL, "Cytokine profiles in schizophrenic patients treated with risperidone: a 3-month follow-up study", Prog Neuropsychopharmacol Biol Psychiatry, 26, pp.33~39 (2002)
48. Himmerich H, "Impact of antipsychotics on cytokine production in-vitro", J Psychiatr Res, 45, pp.1358~1365 (2011)
49. Reimer T, "poly(I:C) and LPS induce distinct IRF3 and NF-kappaB signaling during type-I IFN and TNF responses in human macrophages", J Leukoc Biol, 83, pp.1249~1257 (2008)
50. Weber F, "Double-stranded RNA is produced by positive-strand RNA viruses and DNA viruses but not in detectable amounts by negative-strand RNA viruses", J Virol, 80, pp.5059~5064 (2006)
51. Kowalski J, "In-vitro immunomodulatory effects of haloperidol and perazine in schizophrenia", World J Biol Psychiatry, 1, pp.190~196 (2000)
52. Kowalski J, "Neuroleptics normalize increased release of interleukin- 1beta and tumor necrosis factor-alpha from monocytes in schizophrenia", Schizophr Res, 50, pp.169~175 (2001)
53. Kim YK, "Relationships between interleukins, neurotransmitters and psychopathology in drug-free male schizophrenics", Schizophr Res, 44, pp.165~175 (2000)
54. Pollmächer T, "Plasma levels of cytokines and soluble cytokine receptors during treatment with haloperidol", Am J Psychiatry, 154, pp.1763~1765 (1997)
55. Yao JK, "Membrane polyunsaturated fatty acids and CSF cytokines in patients with schizophrenia", Prostaglandins Leukot Essent Fatty Acids, 69, pp.429~436 (2003)
56. Song C, "Immunosuppressive effects of clozapine and haloperidol: enhanced production of the interleukin-1 receptor antagonist", Schizophr Res, 42, pp.157~164 (2000)
57. Al-Amin MM, "Effect of different antipsychotics on cytokine production after immunologically stimulated pbmc culture", Int Neuropsychiatr Dis J, 1, pp.35~45 (2013)

관련 논문AI추천